{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-056922","form_type":"8-K","ticker":"NAMS","cik":"0001936258","company_name":"NewAmsterdam Pharma Co N.V.","filed_at":"2024-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.339213+00:00","generated_at":"2026-06-05T05:03:53.865584+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"NewAmsterdam Pharma posts updated investor presentation; no material new data","bullets":["Company posted updated corporate investor presentation on its website on March 4, 2024.","Presentation contains no new financial results, guidance, or material operational updates.","No earnings, M&A, or clinical data disclosed in the filing or exhibit.","Routine update typical for investor relations purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-056922","json":"https://secwatch.observer/filing/0001193125-24-056922.json","markdown":"https://secwatch.observer/filing/0001193125-24-056922.md","text":"https://secwatch.observer/filing/0001193125-24-056922.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1936258/000119312524056922/0001193125-24-056922-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1936258/000119312524056922/d759933d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T05:03:53.865584+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}